

Learn about Revumenib (Revuforj) side effects, from common symptoms like nausea to serious warnings like differentiation syndrome and QTc prolongation.
If you or a loved one is starting Revumenib (brand name Revuforj), knowing what side effects to expect — and which ones need immediate medical attention — can help you feel more prepared and in control of your treatment.
Revumenib is a powerful targeted therapy for acute leukemia, and like most cancer treatments, it comes with side effects. Some are mild and manageable. Others are serious and require quick action. This guide covers both, based on FDA labeling and clinical trial data.
Revumenib is a menin inhibitor made by Syndax Pharmaceuticals and sold under the brand name Revuforj. It is approved for the treatment of relapsed or refractory acute leukemia with a KMT2A translocation (in adults and children 1 year and older) and for relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation.
For a deeper look at how it works, see our guide on Revumenib's mechanism of action. For dosing details, check out What Is Revumenib?
The following side effects were reported frequently in clinical trials. Many are manageable with supportive care, but you should always tell your doctor about any new or worsening symptoms.
Your doctor will monitor your blood work regularly. Common lab changes include:
You may not feel these changes, which is why regular blood tests are so important during treatment.
Revumenib carries two boxed warnings — the most serious type of warning the FDA can require. These are:
This is a potentially fatal condition that can occur when leukemia cells begin to mature rapidly in response to treatment. Symptoms include:
What to do: If you experience any combination of these symptoms, contact your doctor immediately or go to the emergency room. Differentiation syndrome is treatable when caught early, usually with corticosteroids.
Revumenib can affect the electrical activity of your heart, causing a condition called QTc prolongation. In rare cases, this can lead to a dangerous heart rhythm called Torsades de Pointes. Symptoms may include:
What to do: Call your doctor or go to the ER immediately if you experience any of these. Your doctor will monitor your heart with ECGs — weekly for the first 4 weeks and monthly after that.
Revumenib can cause fetal harm. If you are pregnant or could become pregnant, this is critical information:
Do not breastfeed during treatment with Revumenib or for 1 week after the last dose.
Revumenib is approved for pediatric patients aged 1 year and older with confirmed KMT2A-rearranged acute leukemia. It has not been studied in children under 1 year of age.
Here are some general tips for managing common side effects while on Revumenib:
Every medication has side effects, and Revumenib is no exception. The important thing is to be informed, stay in close contact with your medical team, and report any new symptoms promptly. Many side effects are manageable, and early detection of serious ones like differentiation syndrome and QTc prolongation can be life-saving.
If you are having trouble finding or affording Revumenib, Medfinder can help you locate it in stock near you. You can also learn about savings programs and patient assistance to reduce your costs.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.